TITLE

Classical Hodgkin's lymphoma: past, present and future perspectives

AUTHOR(S)
Eyre, Toby A.; King, Andrew J.; Collins, Graham P.
PUB. DATE
November 2013
SOURCE
British Journal of Hospital Medicine (17508460);Nov2013, Vol. 74 Issue 11, p612
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article presents treatment perspectives for classical Hodgkin's lymphoma. It mentions the treatment regimen usually involved invasive laparotomies, chemotherapy, and radiotherapy. It highlights clinical trials aimed at maximizing cure, minimizing toxicity and introducing targeted therapies. Information on the epidemiology, diagnosis and staging, pathology, and prognosis of the disease and its management in younger patients, relapse, and autologous and allogeneic transplantation is provided.
ACCESSION #
91951405

 

Related Articles

  • Chemo is as effective before and after.  // Case Management Advisor;Nov2011, Vol. 22 Issue 11, p128 

    The article discusses a study at The University of Texas MD Anderson Cancer Center, which revealed that chemotherapy given before or after breast-conserving therapy (BCT) does not have an impact on long-term local-regional outcomes, thereby attributing the success to biologic factors.

  • End-of-treatment but not interim PET scan predicts outcome in nonbulky limited-stage Hodgkin’s lymphoma. Barnes, J. A.; LaCasce, A. S.; Zukotynski, K.; Israel, D.; Feng, Y.; Neuberg, D.; Toomey, C. E.; Hochberg, E. P.; Canellos, G. P.; Abramson, J. S. // Annals of Oncology;Apr2011, Vol. 22 Issue 4, p910 

    Background: Early interim positron emission tomography (PET) scans appear powerfully predictive of outcome in Hodgkin’s lymphoma (HL), particularly in advanced-stage disease where it has been predominantly studied. The prognostic value of interim PET in limited-stage patients with...

  • Hodgkin's Lymphoma in Adults. Rancea, Michaela; Engert, Andreas; von Tresckow, Bastian; Halbsguth, Teresa; Behringer, Karolin; Skoetz, Nicole // Deutsches Aerzteblatt International;3/14/2013, Vol. 110 Issue 11, p177 

    Background: With an incidence of 2 to 3 cases per 100 000 persons per year, Hodkgin's lymphoma (HL) is rare, but nonetheless one of the most common cancers in young adults. Improved treatment has made HL curable even in advanced stages, but controversy still surrounds a number of issues in...

  • Malignant pleural mesothelioma. CHEN, SHEREE E.; PACE, MAKALA B. // American Journal of Health-System Pharmacy;3/1/2012, Vol. 69 Issue 5, p377 

    Purpose. The etiology, diagnosis, staging, and management of malignant pleural mesothelioma (MPM) are reviewed, with an emphasis on clinical trials of newer approaches to first-line, second-line, and adjuvant chemotherapy. Summary. In the past decade, more effective chemotherapy regimens have...

  • Radiation Oncology Management of Extrapulmonary Small Cell Cancer. Poncelet, Tracy; Schallenkamp, John Mm // Radiation Therapist;Spring2012, Vol. 21 Issue 1, p100 

    The article offers information on the management and treatment of extrapulmonary small cell carcinoma (EPSCC). It stated that EPSCC is a rare form of cancer that arises in sites such as the stomach, small bowel, salivary glands, and others, It also discuses about multi-institutional studies...

  • The Case for Chemotherapy Alone for Limited-Stage Hodgkin's Lymphoma. Connors, Joseph M. // Oncologist;Aug2012, Vol. 17 Issue 8, p1011 

    The author offers his opinion on a study by R. M. Meyer and colleagues, which investigated differences in outcome when patients with limited-stage Hodgkin's Disease (HD) were treated with only chemotherapy with doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) or with subtotal lymph...

  • Osteosarcoma: Evolution of Treatment Paradigms. Jaffe, Norman; Puri, Ajay; Gelderblom, Hans // Sarcoma;2013, p1 

    This paper reviews the contribution of chemotherapy in the conquest of osteosarcoma. It discusses how the treatment of osteosarcoma has evolved over the last five decades, resulting in a more than fivefold increase in survival. Though the initial improvements in survival were dramatic,...

  • Some Children With Hodgkin Lymphoma May Not Require Radiation Therapy. McBride, Deborah // ONS Connect;Sep2012, Vol. 27 Issue 9, p21 

    The article offers information on a study, which reveals that children with Hodgkin lymphoma with favorable clinical feature may not require radiation therapy. It states that the study found that children who were treated with radiation therapy had five-year survival rates. It highlights that it...

  • The Case for Combined-Modality Therapy for Limited-Stage Hodgkin's Disease. Hill-Kayser, Christine E.; Plastaras, John P.; Tochner, Zelig; Glatstein, Eli // Oncologist;Aug2012, Vol. 17 Issue 8, p1006 

    The authors discuss a study by R. M. Meyer and colleagues, which investigated differences in outcome when patients with limited-stage Hodgkin's Disease (HD) were randomized to receive only chemotherapy with doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) or treatment that included...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics